UNITED STATES SECURITIES AND
    EXCHANGE COMMISSION
    Washington, D.C.
    20549
 
 
    Form 10-K/A
    Amendment No. 1
 
 
    FOR
    ANNUAL AND TRANSITION REPORTS
    PURSUANT TO SECTIONS 13 OR 15(d) OF THE
    SECURITIES EXCHANGE ACT OF 1934
 
    |  |  |  | 
| (Mark One) |  |  | 
|  | 
| 
    þ
 |  | ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 | 
|  |  | For the fiscal year ended
    December 31, 2007 | 
| 
    o
 |  | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
    SECURITIES EXCHANGE ACT OF 1934 | 
|  |  | For the transition period
    from          to | 
 
    Commission file
    number: 1-32381
 
 
    HERBALIFE
    LTD.
    (Exact Name of Registrant as
    Specified in Its Charter)
 
    |  |  |  | 
| 
    Cayman Islands
 |  | 98-0377871 | 
| (State or Other Jurisdiction
    of |  | (I.R.S. Employer | 
| 
    Incorporation or
    Organization)
 |  | Identification
    No.) | 
 
    |  |  |  | 
| 
    P.O. Box 309GT
 |  | 90067 | 
| 
    Ugland House, South Church StreetGrand Cayman, Cayman Islands
 (Address of Principal
    Executive Offices)
 |  | (Zip Code) | 
 
    (310) 410-9600
    (Registrants telephone
    number, including area code)
 
    Securities registered pursuant to Section 12(b) of the
    Act:
 
    |  |  |  |  |  | 
| 
    Title of Each Class
 |  | 
    Name of Each Exchange on Which Registered
 | 
| 
    Common Shares, par value $0.002 per share
 |  |  | New York Stock Exchange |  | 
 
    Securities registered pursuant to Section 12(g) of the
    Act:
    None
 
    Indicate by check mark if the registrant is a well-known
    seasoned issuer, as defined in Rule 405 of the Securities
    Act.  Yes þ     No o
    
 
    Indicate by check mark if the registrant is not required to file
    reports pursuant to Section 13 or Section 15(d) of the
    Act.  Yes o     No þ
    
 
    Indicate by check mark whether the registrant: (1) has
    filed all reports required to be filed by Section 13 or
    15(d) of the Securities Exchange Act of 1934 during the
    preceding 12 months (or for such shorter period that the
    Registrant was required to file such reports), and (2) has
    been subject to such filing requirements for the past
    90 days.  Yes þ     No o
    
 
    Indicate by check mark if disclosure of delinquent filers
    pursuant to Item 405 of
    Regulation S-K
    (§ 229,405 of this chapter) is not contained herein,
    and will not be contained, to the best of registrants
    knowledge, in definitive proxy or information statements
    incorporated by reference in Part III of this
    Form 10-K
    or any amendment to this
    Form 10-K.  o
    
 
    Indicate by check mark whether the registrant is a large
    accelerated filer, an accelerated filer, a non-accelerated
    filer, or a smaller reporting company. See the definitions of
    large accelerated filer, accelerated
    filer and smaller reporting company in Rule
    12b-2 of the Exchange Act. (Check one):
 
    |  |  |  |  |  |  |  | 
| 
    Large accelerated filer
    þ
    
 |  | Accelerated filer
    o |  | Non-accelerated
    filer o (Do not check if a smaller reporting company)
 |  | Smaller Reporting
    company o | 
 
    Indicate by check mark whether registrant is a shell company (as
    defined in
    Rule 12b-2
    of the Exchange
    Act).  Yes o     No þ
    
 
    There were 65,114,740 common shares outstanding as of
    April 28, 2008. The aggregate market value of the
    Registrants common shares held by non-affiliates was
    approximately $2,542 million as of June 29, 2007,
    based upon the last reported sales price on the New York
    Stock Exchange on that date of $39.65.
 
    DOCUMENTS
    INCORPORATED BY REFERENCE
 
    None.
 
 
 
 
    EXPLANATORY
    NOTE
 
    We are filing this Amendment No. 1 (this
    Amendment) to our Annual Report on
    Form 10-K
    for the fiscal year ended December 31, 2007, which was
    originally filed with the Securities and Exchange Commission
    (the SEC) on February 26, 2008 (the
    Original
    Form 10-K)
    to correct certain errant biographical information with respect
    to Gregory Probert, our former President and Chief Operating
    Officer, which, as previously disclosed in our Current Report on
    Form 8-K
    filed with the SEC on April 25, 2008, was only recently
    brought to the Companys attention.
 
    Part I, Item 1 and Part III, Item 10 of the
    Original
    Form 10-K
    are hereby amended and restated in their entirety as set forth
    in this Amendment to correct the errant biographical information
    with respect to Mr. Probert. In connection with the filing
    of this Amendment and pursuant to SEC
    rule 12b-15,
    we are filing as exhibits to this Amendment new certifications
    of our principal executive officer and principal financial
    officer under Part IV, Item 15 hereof.
 
    Other than those changes outlined above, there are no changes to
    the Original
    Form 10-K.
    This Amendment does not change our previously reported financial
    statements or the other disclosures contained in the Original
    Form 10-K.
    This Amendment does not reflect events occurring after the
    filing of the Original
    Form 10-K,
    nor does it modify or update disclosures therein in any way
    other than as required to reflect the amendments described
    above. Among other things, forward-looking statements made in
    the Original
    Form 10-K
    have not been revised to reflect events that occurred or facts
    that became known to us after the filing of the Original
    Form 10-K,
    and such forward looking statements should be read in their
    historical context.
    
    2
 
 
 
    PART I
 
 
    GENERAL
 
    We are a global network marketing company that sells weight
    management, nutritional supplement, energy & fitness
    products and personal care products. We pursue our mission of
    changing peoples lives by providing a
    financially rewarding business opportunity to distributors and
    quality products to distributors and customers who seek a
    healthy lifestyle. We are one of the largest network marketing
    companies in the world with net sales of approximately
    $2.1 billion for the fiscal year ended December 31,
    2007. We sell our products in 65 countries through a network of
    over 1.7 million independent distributors. In China, in
    order to comply with local laws and regulations, we sell our
    products through retail stores and an employed sales force. We
    believe the quality of our products and the effectiveness of our
    distribution network, coupled with geographic expansion, have
    been the primary reasons for our success throughout our
    28-year
    operating history.
 
    We offer science based products in four principal categories:
    weight management, targeted nutrition, energy &
    fitness and Outer Nutrition. The weight management product
    portfolio includes meal replacement shakes, weight-loss
    enhancers, appetite suppressors and a variety of healthy snacks.
    Our collection of targeted nutrition products includes dietary
    supplements which contain quality herbs, vitamins, minerals and
    natural ingredients that support total well-being and long-term
    good health. The energy & fitness category includes
    energy and isotonic drinks to support a healthy active
    lifestyle. Our Outer Nutrition products include skin cleansers,
    moisturizers and lotions with antioxidants, as well as
    anti-aging products. Weight management, targeted nutrition,
    energy & fitness and Outer Nutrition accounted for
    63.4%, 20.2%, 4.2% and 6.7% of our net sales in fiscal year
    2007, respectively.
 
    We believe that the direct-selling channel is ideally suited to
    marketing our products, because sales of weight management,
    nutrition and personal care products are strengthened by ongoing
    personal contact between retail consumers and distributors. This
    personal contact may enhance consumers nutritional and
    health education as well as motivate consumers to begin and
    maintain wellness and weight management programs. In addition,
    many of our distributors use our products themselves, and can
    therefore provide first-hand testimonials of product
    effectiveness to consumers, which often serve as a powerful
    sales tool.
 
    We are focused on building and maintaining our distributor
    network by offering financially rewarding and flexible career
    opportunities through sales of quality, innovative and
    efficacious products to health conscious consumers. We believe
    the income opportunity provided by our network marketing program
    appeals to a broad cross-section of people throughout the world,
    particularly those seeking to supplement family income, start a
    home business or pursue entrepreneurial, full and part-time,
    employment opportunities. Our distributors, who are independent
    contractors, can profit from selling our products and can also
    earn royalties and bonuses on sales made by the other
    distributors whom they recruit to join their sales organizations.
 
    We enable distributors to maximize their potential by providing
    a broad array of motivational, educational and support services.
    We motivate our distributors through our performance-based
    compensation plan, individual recognition, reward programs and
    promotions, and participation in local, national and
    international Company-sponsored sales events such as
    Extravaganzas. We are committed to providing professionally
    designed educational training materials that our distributors
    can use to enhance recruitment and maximize their sales. We and
    our distributor leadership conduct thousands of training
    sessions each year throughout the world to educate and motivate
    our distributors. These training events teach our distributors
    not only how to develop invaluable business-building and
    leadership skills, but also how to differentiate our products to
    consumers. Our corporate-sponsored training events provide a
    forum for distributors, who otherwise operate independently, to
    share ideas with us and each other. In addition, we operate an
    internet-based Herbalife Broadcasting Network, which delivers
    worldwide, educational, motivational and inspirational content,
    including addresses from our Chief Executive Officer, to our
    distributors. Our efficient and effective distribution,
    logistics and customer care support system assists our
    distributors by providing same day, or
    next-day
    sales capabilities and support services. We further aid our
    distributors by generating additional demand for our products
    through traditional marketing and public relations activities,
    such as television ads, sporting event sponsorships and
    endorsements.
    
    3
 
 
    Our
    Competitive Strengths
 
    We believe that our success stems from our ability to motivate
    our distributor network with a range of quality, innovative and
    efficacious products that appeal to consumer preferences for
    healthy living. We have been able to achieve sustained and
    profitable growth by capitalizing on the following competitive
    strengths:
 
    Distributor
    Base
 
    As of December 2007, we had over 1.7 million distributors,
    which includes approximately 129,000 China sales representatives
    and employees. Collectively we refer to this group as
    distributors. Approximately 473,000 of our
    1.7 million distributors have become sales leaders, which
    are comprised of approximately 451,000 supervisors in the 64
    countries where we use our traditional marketing plan and 22,000
    China sales employees operating under our China marketing plan.
    Collectively we refer to this group as sales
    leaders. We believe that the distributors who have not
    attained supervisor level can be segmented into three general
    categories based on their product order patterns: discount
    buyers, small retailers and potential supervisors. We define
    discount buyers as customers who have signed up as distributors
    to enjoy a discount on their purchases; small retailers as
    product users and sales people who generate modest sales to
    friends and family; and potential supervisors as distributors
    who are proactively developing a business with the intention of
    qualifying to become a supervisor. In 2007, excluding China,
    distributor orders for these three general categories were
    approximately 52%, 26% and 22%, respectively. For the
    approximately 451,000 supervisors in our organization, the
    marketing plan encourages active participation in the business
    including building down-line sales organizations of their own,
    which can serve to increase their income and increase our
    product sales. Sales leaders contribute significantly to our
    sales.
 
    Product
    Portfolio
 
    We are committed to building distributor, customer and brand
    loyalty by providing a diverse portfolio of health-oriented and
    wellness products. The breadth of our product offerings enables
    our distributors to sell a comprehensive package of products
    designed to simplify weight management and nutrition. Many of
    our product formulations have been in existence for years;
    however, we continually review, and if necessary, improve our
    product formulations, based upon developments in nutrition
    science. We believe that the longevity and variety in our
    product portfolio significantly enhance our distributors
    abilities to build their businesses.
 
    Nutrition
    Science-Based Product Development
 
    We continue to emphasize and make investments in science-based
    product development in the fields of weight management,
    nutrition and personal care. We have a growing internal team of
    scientists dedicated to continually evaluating opportunities to
    enhance our existing products and to develop new science-based
    products. These product development efforts are reviewed by
    prominent doctors and world-renowned scientists who constitute
    our Scientific Advisory Board and Nutrition Advisory Board. In
    addition, we have provided donations to assist in the
    establishment of the Mark Hughes Cellular and Molecular Lab at
    UCLA, or the UCLA Lab, and we continue to rely on their
    expertise. We believe that the UCLA Lab provides opportunities
    for Herbalife to access cutting-edge science in herbal research
    and nutrition. In 2007, Herbalife awarded a research grant to
    the National Center for Natural Products Research at the
    University of Mississippi School of Pharmacy, or NCNPR. The
    grant will allow NCNPR scientists to identify and study the
    biologically active chemicals found in botanicals, which may be
    used in the development of future dietary supplements and skin
    care products for Herbalife.
 
    Scalable
    Business Model
 
    Our business model enables us to grow our business with only
    moderate investment in our infrastructure and other fixed costs.
    With the exception of our China business, we require no
    Company-employed sales force to market and sell our products. We
    incur no direct incremental cost to add a new distributor in our
    existing markets, and our distributor compensation varies
    directly with sales. In addition, our distributors bear the
    majority of our consumer marketing expenses, and supervisors
    sponsor and coordinate a large share of distributor recruiting
    and training initiatives. Furthermore, we can readily increase
    production and distribution of our products as a result of our
    numerous third party manufacturing relationships as well as our
    global footprint of in-house distribution centers.
    
    4
 
 
    Geographic
    Diversification
 
    We have a proven ability to establish our network marketing
    organization in new markets. Since our founding 28 years
    ago, we have expanded our presence into 65 countries. While
    sales within our local markets may fluctuate due to economic,
    market and regulatory conditions, competitive pressures,
    political and social instability or for Company-specific
    reasons, we believe that our geographic diversity mitigates our
    financial exposure to any particular market.
 
    Experienced
    Management Team
 
    Our management team is led by Michael O. Johnson who became our
    Chief Executive Officer after spending 17 years with The
    Walt Disney Company, where he most recently served as President
    of Walt Disney International. In 2007, he was named Chairman.
    Since joining our Company, Mr. Johnson has assembled a team
    of experienced executives, including Gregory Probert, President
    and Chief Operating Officer and formerly Chief Executive Officer
    of DMX Music and Chief Operating Officer of The Walt Disney
    Companys Buena Vista Home Entertainment division; Richard
    Goudis, Chief Financial Officer and formerly Chief Operating
    Officer of Rexall Sundown; Brett R. Chapman, General
    Counsel and formerly Senior Vice President and Deputy General
    Counsel of The Walt Disney Company; and Steve Henig, Ph.D.,
    Chief Scientific Officer with responsibility for our product
    research and development, and formerly Senior Vice President of
    Ocean Spray Cranberries, Inc.
 
    Our
    Business Strategy
 
    We believe that our network marketing model is the most
    effective way to sell our products. Our objective is to increase
    the recruitment, retention, retailing and productivity of our
    distributor base by pursuing the following strategic initiatives:
 
    Major
    Market Strategy
 
    We look to optimize country operating models, further aligning
    resources to fuel growth in high potential markets, develop
    lower-cost models where appropriate and centralize key regional
    functions. Expanding in China represents a significant growth
    opportunity for us as we believe that China could become one of
    the largest direct-selling markets in the world over the next
    several years. To address this opportunity, we have assembled a
    management team with direct selling experience, secured a
    headquarters location in Shanghai, expanded our manufacturing
    capacity in our Suzhou, China factory and in July 2007, received
    a direct-selling license for the Jiangsu province. We are in the
    process of opening retail locations and pursuing direct-selling
    licenses in additional provinces. Through December 2007, we have
    opened 90 retail stores in 29 provinces. Other critical major
    market strategies include developing an Eastern European
    strategy, nurturing Brazils transition to a better balance
    of retailing, retention and recruiting, and identifying new
    untapped markets.
 
    Product
    Strategy
 
    We are committed to providing our distributors with unique,
    innovative products to help them increase sales and recruit new
    distributors. Product development is focused on obesity,
    anti-aging, fitness, childrens health, and immunity
    enhancers. On an ongoing basis we will augment our product
    portfolio with additional science-based products and, as
    appropriate, will bundle products addressing similar health
    concerns into packages and programs. We are establishing a core
    set of products that will be available in all markets around the
    world. We are also empowering regional and country managers to
    develop unique products that are specific to their markets to
    ensure that local consumer needs can be met. Additionally, each
    year we plan to have mega launches of products
    and/or
    programs to generate continual excitement among our
    distributors, to add to our core set of products and to support
    our distributor DMOs. These mega launches will
    generally target specific market segments deemed strategic to
    us, such as the 2007 introduction of a childrens line to
    target
    stay-at-home
    moms and a sports and fitness line to target consumers with
    active lifestyles.
    
    5
 
 
    Distributor
    Strategy
 
    We continue to increase our investment in events and promotions
    as a catalyst to help our distributors improve the effectiveness
    and productivity of their businesses. We will attempt to
    globalize best-practice business methods to enable our
    distributors to improve their penetration in existing markets.
    We refer to these business methods as DMOs and they include
    Nutrition Clubs, the Total Plan, Wellness Coach and
    Internet/Sampling. We also introduced BizWorks, a business
    system which assists our distributors in building their
    businesses more efficiently while better servicing their
    existing customers. And finally, to increase brand awareness
    among potential customers and distributors, we have entered into
    marketing alliances, created Team Herbalife and
    rolled-out a style guide and brand asset library so that our
    distributors have access to the Herbalife brand logo for use in
    their marketing efforts.
 
    Infrastructure
    Strategy
 
    In 2003, we embarked upon a strategic initiative to
    significantly upgrade our technology infrastructure throughout
    the world. We are implementing an Oracle enterprise-wide
    technology solution, with a scalable and stable open
    architecture platform, to enhance our efficiency and
    productivity as well as that of our distributors. In addition,
    we are upgrading our internet-based marketing and distributor
    services platform with tools such as BizWorks and
    MyHerbalife.com and we have invested in business intelligence
    tools to enable better analysis of our business. In 2008, we
    expect to execute the next stage of stabilization upgrades for
    the software application tier of the Oracle platform with
    implementation thereof across multiple regions in 2008 and 2009.
    Additionally, we continue to invest in our employees through a
    comprehensive and global organizational development program.
 
    Product
    Overview
 
    For 28 years, our products have been designed to help
    distributors and customers from around the world lose weight,
    improve their health and experience life-changing results. We
    have built our heritage on developing formulas that blend the
    best of nature with innovative techniques from nutrition
    science, appealing to the growing base of consumers seeking
    differentiated products and desiring a healthier lifestyle.
 
    As of December 31, 2007, we marketed and sold 131 products
    encompassing over 3,500 SKUs through our distributors and had
    approximately 1,803 trademarks worldwide. We group our products
    into four primary categories: weight management, targeted
    nutrition, energy & fitness and Outer Nutrition. Our
    products are often sold in programs, which are comprised of a
    series of related products designed to simplify weight
    management and nutrition for our consumers and maximize our
    distributors cross-selling opportunities. These programs
    target specific consumer market segments, such as women, men or
    children, as well as weight-management customers and individuals
    looking to enhance their overall well-being.
 
    The following table summarizes our products by product category.
 
    |  |  |  |  |  | 
| 
    Product Category
 |  | 
    Description
 |  | 
    Representative Products
 | 
|  | 
| 
    Weight Management (63.4% of 2007 net sales)
 |  | Meal replacement, weight-loss enhancers and a variety of healthy
    snacks |  | Formula 1 Healthy Meal, Personalized Protein Powder, Total
    Control®,
    High Protein Bars and Snacks | 
| 
    Targeted Nutrition (20.2% of 2007 net sales)
 |  | Dietary and nutritional supplements containing quality herbs,
    vitamins, minerals and other natural ingredients |  | Niteworks®,
    Garden
    7®
    phytonutrient supplement, Best
    Defense®
    for improved immune system,  Kids Line | 
| 
    Energy & Fitness (4.2% of 2007 net sales)
 |  | Products that support a healthy active lifestyle |  | Liftoff®
    energy drink, H3OTM hydration drink | 
| 
    Outer Nutrition (6.7% of 2007 net sales)
 |  | Skin cleansers, moisturizers, lotions, shampoos and conditioners |  | Skin
    Activator®
    Anti-Aging line,
    NouriFusion®
    skin care line | 
| 
    Literature, Promotional and Other Products (5.5% of 2007 net sales)
 |  | Sales aids, informational audiotapes, CDs, DVDs and start-up kits |  | International Business Packs, BizWorks | 
    
    6
 
 
    Weight
    Management
 
    Weight Management is our largest product category representing
    63.4% of our net sales for the year 2007. Formula 1, our
    best-selling product, is a healthy meal with soy protein,
    essential vitamins, minerals and nutrients that is available in
    seven delicious flavors and can help support weight management.
    It has been part of our basic weight management program for
    28 years and generated approximately 30% of our retail
    sales for the year 2007. Personalized Protein Powder is a soy
    and whey protein product developed to be added to Formula 1 to
    boost protein intake and decrease hunger. Weight-loss enhancers,
    including Total
    Control®,
    address specific challenges associated with dieting, such as
    lack of energy, hunger and food craving, fluid retention,
    decreased metabolism and digestive challenges, by building
    energy, boosting metabolism, curbing appetite and helping to
    promote weight loss. Healthy snacks are formulated to provide
    between-meal nutrition and satisfaction.
 
    Targeted
    Nutrition
 
    We market numerous dietary and nutritional supplements designed
    to meet our customers specific nutritional needs. Each of
    these supplements contains quality herbs, vitamins, minerals and
    other natural ingredients and focuses on specific lifestages of
    our customers, including women, men, children and those with
    health concerns, including heart health, healthy aging,
    digestive health, or immune solutions.
    Niteworks®
    is a product developed in conjunction with Nobel Laureate in
    Medicine, Dr. Louis Ignarro, that supports energy,
    circulatory and vascular health and enhances blood flow to the
    heart, brain and other vital organs. Garden
    7®
    is designed to provide the phytonutrient benefits of seven
    servings of fruits and vegetables and has anti-oxidant and
    health-boosting properties. Best
    Defense®
    is an effervescent drink that boosts immunity. In 2007, we
    introduced a new Kids Line including shakes and improved
    multivitamins which provide essential nutrition including
    protein, fiber and 100% of key nutrients to meet growing
    kids daily needs.
 
    Energy
    and Fitness
 
    We have entered into the high growth energy drink category with
    the introduction of
    Liftoff®,
    an innovative, effervescent energy product with B-vitamins,
    ginseng, ginger and caffeine to increase energy and improve
    mental clarity for better performance throughout the day. In
    2007, we launched
    H3OTM
    Fitness Drink to provide rapid hydration, sustained energy plus
    antioxidant protection for people living a healthy, active
    lifestyle.
 
    Outer
    Nutrition
 
    Our Outer Nutrition products complement our weight-management
    and targeted nutrition products and aim to improve the
    appearance of the body, skin and hair. These products include
    skin cleansers, toners, moisturizers and facial masks, shampoos
    and conditioners, body-wash items and a selection of fragrances
    for men and women.
    NouriFusion®
    is a personal care product line that utilizes vitamin A, C and E
    to provide benefits to the skin. In 2006, we launched an
    extension of our successful Skin
    Activator®
    product, an advanced cream based glucosamine complex to reduce
    the appearance of fine lines and wrinkles, into a full line of
    anti-aging products.
 
    Literature,
    Promotional and Other Products
 
    We also sell literature and promotional materials, including
    sales aids, informational audiotapes, videotapes, CDs and DVDs
    designed to support our distributors marketing efforts, as
    well as
    start-up
    kits called International Business Packs for new
    distributors. In 2006, we introduced BizWorks, a customizable
    retail website for our distributors to enhance the on-line
    experience and improve their productivity.
 
    Product
    Development
 
    We are committed to providing our distributors with unique,
    innovative science-based products to help them increase
    recruitment, retention and retailing. We believe this can be
    best accomplished in part by introducing new products and by
    upgrading, reformulating and repackaging existing product lines.
    Our internal team of scientists and product developers
    collaborate with the Companys Nutrition Advisory Board and
    Scientific Advisory Board to formulate, review and evaluate new
    product ideas. Once a particular market opportunity has been
    identified, our
    
    7
 
 
    scientists along with our marketing and sales teams work closely
    with distributors to effect a successful development and launch
    of the product.
 
    A new product development process was implemented globally to
    accelerate the introduction of new products and to improve the
    launch of products. Cross-functional teams from Product
    Marketing, Product Development, Sciences, Licensing,
    Manufacturing and Finance were formed and assigned to major
    product initiatives.
 
    The product development process is a stage-gate process based on
    best in class practices in our industry. The process
    consists of five stages: identification, feasibility assessment,
    development, launch and learn. The project teams obtain
    approvals from a corporate steering team comprised of key
    executives in the Company. The process defines each
    departments roles and responsibilities and sets clear
    deliverables for each stage. It creates a succinct process from
    the beginning of the development cycle to the end.
 
    New product ideas are generated and narrowed down to high
    potential ideas that fill our business needs and conform to our
    overall strategy. We test the most promising ideas with
    distributors and customers using a variety of qualitative and
    quantitative tools. This testing is followed by a feasibility
    assessment which includes a review of product and package
    prototypes, product positioning and messaging, process design,
    analysis of manufacturing issues and providing preliminary
    financial projections of product sales. The next stage is the
    development phase in which we finalize the formula, process,
    manufacturing strategy, product positioning, pricing, labeling
    and other related matters. The fourth stage is the launch phase
    in which we prepare promotional and sales materials, complete
    the supply chain plan, create product and financial forecasts,
    and complete other final preparations for launch. After the
    product is launched, we closely track sales performance and the
    lessons learned so we can update and improve the product
    development process. In addition, during the past three years,
    we have significantly increased our investment in clinical
    studies and in our science program to substantiate claims and
    efficacy of our products.
 
    We reorganized our technical team in 2007 for greater efficiency
    in product development as well as to carry out related product
    development strategies both globally and regionally. During
    2007, we also added new talents to our technical and scientific
    teams and additional resources to the Companys Nutrition
    and Scientific Advisory Boards.
 
    The Nutrition Advisory Board is headed by David
    Heber, M.D., Ph.D., Professor of Medicine and Public
    Health at the UCLA School of Medicine, Director of the UCLA
    Center for Human Nutrition and Director of the UCLA Center for
    Dietary Supplement Research in Botanicals. The Nutrition
    Advisory Board has 20 members from 17 countries. It is comprised
    of leading scientists and medical doctors who provide training
    on product usage and give health-news updates through Herbalife
    literature, the Internet and training events around the world.
    Our Scientific Advisory Board is chaired by Dr. Heber and
    has 12 members from six countries. Louis Ignarro, Ph.D.,
    Distinguished Professor of Pharmacology at the UCLA School of
    Medicine and Nobel Laureate in Medicine is also a member of the
    Scientific Advisory Board.
 
    We believe that it is important to maintain our relationships
    with members of our Nutrition Advisory Board and Scientific
    Advisory Board to recognize the time and effort that they expend
    on our behalf. Each member of our Nutrition Advisory Board other
    than Dr. Heber receives a monthly retainer of up to $5,000,
    plus up to $3,000 for every day that they appear at a
    non-southern California distributor event and up to $2,000 for
    every day that they need to travel to such events. Members of
    our Scientific Advisory Board are compensated for their time and
    efforts in the following manner: (1) ten members are paid
    an annual retainer of $5,000 plus travel expenses,
    (2) Dr. Ignarro receives no direct compensation from
    us although we do pay a consulting firm, with which
    Dr. Ignarro is affiliated, a royalty on sales of
    Niteworks®,
    certain healthy heart products, and other products
    that we may mutually designate in the future that are, in each
    case, sold with the aid of Dr. Ignarros consulting,
    promotional or endorsement services, with such amounts totaling
    $1.4 million, $1.0 million and $1.9 million in
    2005, 2006 and 2007, respectively and (3) Dr. Heber
    generally, other than a one time option grant in 2005, receives
    no direct compensation from us although we do reimburse him for
    travel expenses and we do pay to a consulting firm, with which
    Dr. Heber is affiliated, a quarterly consulting fee of
    $75,000.
 
    In 2007, we completed construction and moved into modern,
    state-of-the-art product development laboratories in Torrance,
    California, as well as quality control laboratories in Carson,
    California. This investment will enable our developers,
    scientists and quality control staff to accelerate product
    development, launch products faster and provide a more robust
    quality control program.
    
    8
 
 
    Herbalife also made further contributions to the UCLA Lab. We
    have continually invested in this lab since 2002 with total
    donations of approximately $1.4 million which includes
    donations of lab equipment and software. UCLA agreed that the
    donations would be used for further research and education in
    the fields of weight management and botanical dietary
    supplements. In addition, we have made donations from time to
    time to UCLA to fund research and educational programs. While
    our direct relationship with UCLA is currently limited to
    conducting one ongoing clinical studies, we intend to take full
    advantage of the expertise at UCLA by committing to support
    research that will further our understanding of the benefits of
    phytochemicals.
 
    In 2007, we introduced new flavors of Formula 1 including
    Café Latte and Pina Colada, as well as Protein Bars Deluxe
    and Formula 1 in single serve sachets for Weight Management;
    Kids Shakes and Kids Multi-Vitamins for Targeted Nutrition;
    H3OTM
    Fitness Drink for Energy and Fitness and Skin
    Activator®
    Packettes and Soft Green Line for Outer Nutrition.
 
    We believe our focus on nutrition and botanical science and our
    efforts at combining our internal research and development
    efforts with the scientific expertise of our Scientific Advisory
    Board, the educational skills of the Nutrition Advisory Board
    and the resources of the UCLA Lab should result in meaningful
    product introductions and give our distributors and consumers
    increased confidence in our products.
 
    Network
    Marketing Program
 
    General
 
    Our products are distributed through a global network marketing
    organization comprised of over 1.7 million independent
    distributors in 65 countries, including in China where, due to
    regulations, our sales are conducted through Company operated
    retail stores, sales representatives and employed sales
    management personnel. In China, in the areas where we have a
    direct selling license, our distributors and employees can sell
    Herbalife product outside the retail establishments. In addition
    to helping our distributors achieve physical health and wellness
    through use of our products, we offer our distributors, who are
    independent contractors, attractive income opportunities.
    Distributors may earn income on their own sales and can also
    earn royalties and bonuses on sales made by the distributors in
    their sales organizations. We believe that our products are
    particularly well-suited to the network marketing distribution
    channel because sales of weight management and health and
    wellness products are strengthened by ongoing personal contact
    and coaching between retail consumers and distributors. We
    believe our continued commitment to developing innovative,
    science-based products will enhance our ability to attract new
    distributors as well as increase the productivity and retention
    of existing distributors. Furthermore, our international
    sponsorship program, which permits distributors to sponsor
    distributors in other countries where we are licensed to do
    business and where we have obtained required product approvals,
    provides a significant advantage to our distributors in
    developing and growing their businesses. China has its own
    unique marketing program.
 
    On July 18, 2002, we entered into an agreement with our
    distributors that no material changes adverse to the
    distributors will be made to the existing marketing plan without
    their consent and that we will continue to distribute Herbalife
    products exclusively through our independent distributors. We
    believe that this agreement has strengthened our relationship
    with our existing distributors, improved our ability to recruit
    new distributors and generally increased the long-term stability
    of our business.
 
    Structure
    of the Network Marketing Program
 
    To become a distributor in most markets, a person must be
    sponsored by an existing distributor and must purchase an
    International Business Pack. The International Business Pack is
    a distributor kit available in local languages. The product and
    literature contents in the kits vary slightly to meet individual
    market needs. An example is the large size US IBP, which costs
    $87.95 and includes a canister of Formula 1 shake mix, several
    bottles of different nutritional supplements, Herbal Concentrate
    (Tea),
    Liftoff®
    (an energy drink), and
    Nourifusion®
    (skin care) samples, along with a handy tote, booklets
    describing us, our compensation plan and rules of conduct,
    various training and promotional materials, distributor
    applications and a product catalog. The smaller US version costs
    $54.95 and includes sample products, a handy tote, and
    essentially the same print and promotional materials as included
    in the larger kit version. To become a supervisor or qualify for
    a higher level, distributors must achieve specified volumes of
    product sales or earn certain amounts of royalty overrides
    during specified time periods and
    
    9
 
 
    must re-qualify for the levels once each year. To attain
    supervisor status, a distributor generally must be responsible
    for sales of products representing at least 4,000 volume points
    in one month or 2,500 volume points in two consecutive months.
    China has its own unique marketing program. Volume points are
    point values assigned to each of our products that are usually
    equal in all countries and are based on the suggested retail
    price of U.S. products (one volume point equates to one
    U.S. dollar). Supervisors may then attain higher levels,
    (consisting of the World Team, the Global Expansion Team, the
    Millionaire Team, the Presidents Team, the Chairmans
    Club and the Founders Circle) and earn increasing amounts of
    royalty overrides based on sales in their downline organizations
    and, for members of our Global Expansion Team and above, earn
    production bonuses on sales in their downline organizations.
 
    The following table sets forth the number of our sales leaders
    and supervisor retention rates as of requalification period:
 
    |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | At the end of February |  | 
|  |  | Number of Sales Leaders |  |  | Supervisors Retention Rate |  | 
|  |  | 2005 |  |  | 2006 |  |  | 2007 |  |  | 2005 |  |  | 2006 |  |  | 2007 |  | 
|  | 
| 
    North America
 |  |  | 41,252 |  |  |  | 45,766 |  |  |  | 54,314 |  |  |  | 38.6 | % |  |  | 41.2 | % |  |  | 43.1 | % | 
| 
    Mexico & Central America
 |  |  | 19,055 |  |  |  | 38,356 |  |  |  | 62,683 |  |  |  | 50.6 | % |  |  | 57.4 | % |  |  | 55.2 | % | 
| 
    South America
 |  |  | 28,240 |  |  |  | 40,111 |  |  |  | 51,302 |  |  |  | 33.4 | % |  |  | 32.4 | % |  |  | 32.9 | % | 
| 
    EMEA
 |  |  | 65,485 |  |  |  | 66,103 |  |  |  | 64,862 |  |  |  | 44.0 | % |  |  | 45.0 | % |  |  | 46.2 | % | 
| 
    Asia Pacific (excluding China)
 |  |  | 47,893 |  |  |  | 51,249 |  |  |  | 56,871 |  |  |  | 34.4 | % |  |  | 35.9 | % |  |  | 35.0 | % | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Total Supervisors
 |  |  | 201,925 |  |  |  | 241,585 |  |  |  | 290,032 |  |  |  | 39.7 | % |  |  | 41.5 | % |  |  | 42.5 | % | 
| 
    China Sales Employees
 |  |  |  |  |  |  | 1,987 |  |  |  | 8,759 |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Worldwide Total Sales Leaders
 |  |  | 201,925 |  |  |  | 243,572 |  |  |  | 298,791 |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
    In February of each year, we remove from the rank of supervisor
    those individuals who did not satisfy the supervisor
    qualification requirements during the preceding twelve months.
    Distributors who meet the supervisor requirements at any time
    during the year are promoted to supervisor status at that time,
    including any supervisors who were removed, but who subsequently
    requalified. For the latest twelve month re-qualification period
    ending January 2008, approximately 41.0% of our supervisors
    re-qualified. Typically, distributors who purchase our product
    for personal consumption or for short term weight loss or income
    goals may stay with us for several months to one year while
    supervisors who have committed time and effort to build a sales
    organization generally stay for longer periods. We rely on
    certifications from the selling distributors as to the amount
    and source of product sales to other distributors which are not
    directly verifiable by us. For supervisors to requalify and
    retain their distributor organization and associated earnings,
    they need to earn 4,000 volume points in one month or 2,500
    volume points in each of two consecutive months. In order to
    increase retailing of our products, we have modified our
    requalification criteria to provide that any distributor that
    earns at least 4,000 volume points in any
    12-month
    period can requalify as a supervisor and retain a discount of
    50% from suggested retail prices, but will forfeit their
    distributor organization and associated earnings.
 
    Distributor
    Earnings
 
    Distributor earnings are derived from several sources. First,
    distributors may earn profits by purchasing our products at
    wholesale prices, which are discounted 25% to 50% from suggested
    retail prices, depending on the distributors level within
    our distributor network, and selling our products to retail
    customers or to other distributors. Second, distributors who
    sponsor other distributors and establish their own sales
    organizations may earn (1) royalty overrides, up to 15% of
    product retail sales in the aggregate, (2) production
    bonuses, up to 7% of product retail sales in the aggregate and
    (3) the Mark Hughes bonus, up to 1% of product retail sales
    in the aggregate. Royalty overrides and bonuses together with
    the distributor allowances represent the potential earnings to
    distributors of up to approximately 73% of retail sales. Each
    distributors success is dependent on two primary factors:
    1) the time, effort and commitment a distributor puts into
    his or her Herbalife business and 2) the product sales made
    by a distributor and his or her sales organization.
    
    10
 
 
    Distributors, with the exception of China, earn the right to
    receive royalty overrides upon attaining the level of supervisor
    and above, and production bonuses upon attaining the level of
    Global Expansion Team and above. Once a distributor becomes a
    supervisor, he or she has an incentive to qualify, by earning
    specified amounts of royalty overrides, as a member of the
    Global Expansion Team, the Millionaire Team or the
    Presidents Team, and thereby receive production bonuses of
    up to 7%. We believe that the right of distributors to earn
    royalty overrides and production bonuses contributes
    significantly to our ability to retain our most productive
    distributors.
 
    Many of our non-supervisor distributors join Herbalife to obtain
    a 25% discount on our products and become a discount consumer or
    merely have a part-time income goal in mind. Consequently,
    non-supervisor earnings tend to be relatively low and are not
    tracked by the Company.
 
    Under the regulations published by the Chinese Government,
    direct selling companies are limited to the payment of gross
    compensation to direct sellers of up to a maximum 30% of the
    revenue they generate through their own sales of products to
    consumers. We have incurred and will continue to incur
    substantial ongoing additional costs relating to the inclusion
    in the China business model of Company operated retail stores,
    employed sales management personnel and Company provided
    training and certification procedures for sales personnel,
    features not common elsewhere in our traditional business model.
 
    Distributor
    Motivation and Training
 
    We believe that motivation and training are key elements in
    distributor success and that we and our distributor supervisors
    have established a consistent schedule of events to support
    these needs. We and our distributor leadership conduct thousands
    of training sessions annually on local, regional and global
    levels to educate and motivate our distributors. Every month,
    there are hundreds of
    one-day
    Success Training Seminars held throughout the world. Annually,
    in each major territory or region, there is a
    three-day
    World Team School that focuses on product and business
    development and is typically attended by 2,000 to 10,000
    distributors. Additionally, once a year in each region, we host
    an Extravaganza at which our distributors from the region can
    come to learn about new products, expand their skills and
    celebrate their success. In 2007, such events were held in
    Brazil, Colombia, the United States, Singapore, Germany and
    Mexico. In addition to these training sessions, we have our own
    Herbalife Broadcast Network that we use to provide
    distributors continual training and the most current product and
    marketing information. The Herbalife Broadcast Network can be
    seen on the internet.
 
    Distributor reward and recognition is a significant factor in
    motivating our distributors. In 2007, we invested over
    $64 million in regional and worldwide events and promotions
    to motivate our distributors to achieve and exceed both sales
    and recruiting goals. Examples of our worldwide promotions are
    the 2007 Vacations and the Active World Team Promotion. The 2007
    Vacations offer incentives for distributors to qualify to
    receive a regional vacation. The Active World Team Promotion
    provides cash and recognition incentives to distributors who
    achieve all three requirements for becoming a World Team Member
    and thus have proven themselves adept at building a
    well-balanced business.
 
    Geographic
    Presence
 
    As of December 31, 2007, we conducted business in 65
    countries throughout the world. The following chart sets forth
    the countries we currently operate in as of December 31,
    2007, organized in the Companys five geographic regions,
    and the year in which we commenced operations.
 
    |  |  |  |  |  | 
|  |  | Year 
 |  | 
| 
    Country
 |  | Entered |  | 
|  | 
| 
    North America
 |  |  |  |  | 
| 
    USA
 |  |  | 1980 |  | 
| 
    Canada
 |  |  | 1982 |  | 
| 
    Jamaica
 |  |  | 1999 |  | 
| 
    Mexico and Central America
 |  |  |  |  | 
| 
    Mexico
 |  |  | 1989 |  | 
| 
    Dominican Republic
 |  |  | 1994 |  | 
    
    11
 
 
    |  |  |  |  |  | 
|  |  | Year 
 |  | 
| 
    Country
 |  | Entered |  | 
|  | 
| 
    Panama
 |  |  | 2000 |  | 
| 
    Costa Rica
 |  |  | 2006 |  | 
| 
    El Salvador
 |  |  | 2007 |  | 
| 
    South America
 |  |  |  |  | 
| 
    Venezuela
 |  |  | 1994 |  | 
| 
    Argentina
 |  |  | 1994 |  | 
| 
    Brazil
 |  |  | 1995 |  | 
| 
    Chile
 |  |  | 1997 |  | 
| 
    Colombia
 |  |  | 2001 |  | 
| 
    Bolivia
 |  |  | 2004 |  | 
| 
    Peru
 |  |  | 2006 |  | 
| 
    Asia Pacific
 |  |  |  |  | 
| 
    Australia
 |  |  | 1983 |  | 
| 
    New Zealand
 |  |  | 1988 |  | 
| 
    Japan
 |  |  | 1989 |  | 
| 
    Hong Kong
 |  |  | 1992 |  | 
| 
    Philippines
 |  |  | 1994 |  | 
| 
    Taiwan
 |  |  | 1995 |  | 
| 
    South Korea
 |  |  | 1996 |  | 
| 
    Thailand
 |  |  | 1997 |  | 
| 
    Indonesia
 |  |  | 1998 |  | 
| 
    India
 |  |  | 1999 |  | 
| 
    China
 |  |  | 2001 |  | 
| 
    Macau
 |  |  | 2002 |  | 
| 
    Singapore
 |  |  | 2003 |  | 
| 
    Malaysia
 |  |  | 2006 |  | 
| 
    EMEA
 |  |  |  |  | 
| 
    United Kingdom
 |  |  | 1984 |  | 
| 
    Spain
 |  |  | 1989 |  | 
| 
    Israel
 |  |  | 1989 |  | 
| 
    France
 |  |  | 1990 |  | 
| 
    Germany
 |  |  | 1990 |  | 
| 
    Portugal
 |  |  | 1992 |  | 
| 
    Czech Republic
 |  |  | 1992 |  | 
| 
    Italy
 |  |  | 1992 |  | 
| 
    Netherlands
 |  |  | 1993 |  | 
| 
    Belgium
 |  |  | 1994 |  | 
| 
    Poland
 |  |  | 1994 |  | 
| 
    Denmark
 |  |  | 1994 |  | 
| 
    Sweden
 |  |  | 1994 |  | 
| 
    Russia
 |  |  | 1995 |  | 
| 
    Austria
 |  |  | 1995 |  | 
| 
    Switzerland
 |  |  | 1995 |  | 
| 
    South Africa
 |  |  | 1995 |  | 
    12
 
 
    |  |  |  |  |  | 
|  |  | Year 
 |  | 
| 
    Country
 |  | Entered |  | 
|  | 
| 
    Norway
 |  |  | 1995 |  | 
| 
    Finland
 |  |  | 1995 |  | 
| 
    Greece
 |  |  | 1996 |  | 
| 
    Turkey
 |  |  | 1998 |  | 
| 
    Botswana
 |  |  | 1998 |  | 
| 
    Lesotho
 |  |  | 1998 |  | 
| 
    Namibia
 |  |  | 1998 |  | 
| 
    Swaziland
 |  |  | 1998 |  | 
| 
    Iceland
 |  |  | 1999 |  | 
| 
    Slovak Republic
 |  |  | 1999 |  | 
| 
    Cyprus
 |  |  | 2000 |  | 
| 
    Ireland
 |  |  | 2000 |  | 
| 
    Croatia
 |  |  | 2001 |  | 
| 
    Latvia
 |  |  | 2002 |  | 
| 
    Ukraine
 |  |  | 2002 |  | 
| 
    Estonia
 |  |  | 2003 |  | 
| 
    Lithuania
 |  |  | 2003 |  | 
| 
    Hungary
 |  |  | 2005 |  | 
| 
    Zambia
 |  |  | 2007 |  | 
 
    In late 2007, we changed our geographic regions from seven to
    five regions as part of our on-going Realignment for Growth
    efforts. Historical information presented below relating to the
    geographic regions has been reclassified to conform with current
    geographic presentation.
 
    |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | Number of 
 |  | 
|  |  | Net Sales |  |  | Percent of 
 |  |  | Countries 
 |  | 
|  |  | Year Ended December 31, |  |  | Total Net Sales 
 |  |  | December 31, 
 |  | 
| 
    Geographic Region
 |  | 2005 |  |  | 2006 |  |  | 2007 |  |  | 2007 |  |  | 2007 |  | 
|  |  | (In millions) |  |  |  |  |  |  |  | 
|  | 
| 
    North America
 |  | $ | 303.8 |  |  | $ | 357.6 |  |  | $ | 438.7 |  |  |  | 20.4 | % |  |  | 3 |  | 
| 
    Mexico & Central America
 |  |  | 219.9 |  |  |  | 376.9 |  |  |  | 384.6 |  |  |  | 17.9 | % |  |  | 5 |  | 
| 
    South America
 |  |  | 158.1 |  |  |  | 224.1 |  |  |  | 300.1 |  |  |  | 14.0 | % |  |  | 7 |  | 
| 
    EMEA
 |  |  | 545.3 |  |  |  | 548.0 |  |  |  | 567.7 |  |  |  | 26.5 | % |  |  | 36 |  | 
| 
    Asia Pacific
 |  |  | 339.7 |  |  |  | 378.9 |  |  |  | 454.7 |  |  |  | 21.2 | % |  |  | 14 |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Worldwide
 |  | $ | 1,566.8 |  |  | $ | 1,885.5 |  |  | $ | 2,145.8 |  |  |  | 100.0 | % |  |  | 65 |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
    The top six countries have represented approximately 56%, 58.2%
    and 56.1% of net sales in 2005, 2006, and 2007, respectively,
    reflecting our broad geographical diversification.
 
    After entering a new country, in many instances we experience an
    initial period of rapid growth in sales as new distributors are
    recruited, that is then followed by a decline in sales. We
    believe that a significant factor affecting these markets is the
    opening of other new markets within the same geographic region
    or within the same or similar language or cultural bases. Some
    distributors tend to focus their attention on the business
    opportunities provided by these newer markets instead of
    developing their established sales organizations in existing
    markets. Additionally, in some instances, we have become aware
    that certain sales in certain existing markets were attributable
    to purchasers who distributed our products in countries that had
    not yet been opened. When these countries were opened, the sales
    in existing markets shifted to the newly opened markets,
    resulting in a decline in sales in the existing markets. To the
    extent we decide to open new markets in the future, we will
    continue to seek to minimize the impact on distributor focus in
    existing markets and to ensure that adequate distributor support
    services and other Herbalife systems are in place to support
    growth while maintaining prior sales levels within the region.
    13
 
 
    Manufacturing
    and Distribution
 
    All of our weight management, nutritional and personal care
    products are manufactured for us by third party manufacturing
    companies, with the exception of products distributed in and
    sourced from China, where we have our own manufacturing
    facility. However, we own proprietary formulations for
    substantially all of our weight management products and dietary
    and nutritional supplements. We source our products from
    multiple manufacturers, with our top three suppliers accounting
    for approximately 49.7% of our product purchases in 2007. In
    addition, each of our products can be made available from a
    secondary vendor if necessary. We work closely with our vendors
    in an effort to achieve the highest quality standards and
    product availability. We also have our own quality control lab
    in which we routinely test products received from vendors. We
    have established excellent relationships with our manufacturers
    and continue to obtain improvements in supply services, product
    quality and product delivery. Currently prices of some of our
    key input materials such as soy, whey protein, fructose and
    packaging material are increasing. However, we are confident we
    can offset these increases with our cost reduction programs and
    by raising the prices of our products.
 
    In order to coordinate and manage the manufacturing of our
    products, we utilize a significant demand planning and
    forecasting process that is directly tied to our production
    planning and purchasing systems. Using this sophisticated
    planning software and process allows us to balance our inventory
    levels to provide exceptional service to distributors while
    minimizing working capital and inventory obsolescence.
 
    Our global distribution system features centralized distribution
    and telephone ordering systems coupled with storefront
    distributor service centers. Our major distribution warehouses
    have automated pick-to-light systems which
    consistently deliver high order accuracy and inspection of every
    shipment before it is sent to delivery. Shipping and processing
    standards for orders placed are either the same day or the
    following business day. We have central sales ordering
    facilities for answering and processing telephone orders.
    Operators at these centers are capable of conversing in multiple
    languages.
 
    Our products are distributed to foreign markets either from the
    facilities of our manufacturers or from our Los Angeles or
    Venray, Netherlands distribution centers. Products are
    distributed in the United States market from our Los Angeles
    distribution center, our Memphis distribution center or from our
    sales centers in Dallas and Phoenix. Products distributed
    globally are generally transported by truck, cargo ship or plane
    to our international markets and are warehoused in either one of
    our foreign distribution centers or a contracted third party
    warehouse and distribution center. After the products arrive in
    a foreign market, distributors purchase the products from the
    local distribution center or the associated sales center. The
    products manufactured in Europe are shipped to a centralized
    warehouse facility, from which delivery by truck, ship or plane
    to other international markets occurs.
 
    Product
    Return and Buy-Back Policies
 
    In most markets, our products include a customer satisfaction
    guarantee. Under this guarantee any customer who is not
    satisfied with an Herbalife product for any reason may return it
    or any unused portion of it within 30 days of purchase to
    their distributor from whom it was purchased for a full refund
    from the distributor or credit toward the purchase of another
    Herbalife product. If they return the products to us on a timely
    basis, the distributor may obtain replacement product from us
    for such returned products. In addition, in most jurisdictions,
    we maintain a buy-back program pursuant to which we will
    repurchase products sold to a distributor provided that the
    distributor resigns as an Herbalife distributor, returns the
    product in marketable condition generally within twelve months
    of original purchase and meets certain documentation and other
    requirements. We believe this buy-back policy addresses a number
    of the regulatory compliance issues pertaining to network
    marketing, in that it offers monetary protection to distributors
    who want to exit the business. Product returns, refunds and
    buy-back expenses were approximately 1% of retail sales in each
    of the years 2005, 2006 and 2007.
 
    Management
    Information, Internet and Telecommunication Systems
 
    In order to facilitate our continued growth and support
    distributor activities, we continually upgrade our management
    information, internet and telecommunication systems. These
    systems include: (1) a centralized host computer managed by
    Hewlett Packard in Colorado, which is linked to our
    international markets through a dedicated wide area network that
    provides on-line, real-time computer connectivity and access and
    hosts our legacy
    
    14
 
 
    operating systems and our new Oracle platform; (2) local
    area networks of personal computers within our markets, serving
    our regional administrative staffs; (3) an international
    e-mail
    system through which our employees communicate; (4) a
    standardized Northern Telecom Meridian telecommunication system
    in most of our markets; and (5) internet websites to
    provide a variety of online services for distributors such as
    status of qualifications, meeting announcements, product
    information, application forms, educational materials and, in
    the United States, sales ordering capabilities. These systems
    are designed to provide, among other things, financial and
    operating data for management, timely and accurate product
    ordering, royalty override payment processing, inventory
    management and detailed distributor records. We intend to
    continue to invest in these systems in order to strengthen our
    operating platform.
 
    Regulation
 
    General
 
    In both our United States and foreign markets, we are affected
    by extensive laws, governmental regulations, administrative
    determinations, court decisions and similar constraints. Such
    laws, regulations and other constraints exist at the federal,
    state or local levels in the United States and at all levels of
    government in foreign jurisdictions, including regulations
    pertaining to: (1) the formulation, manufacturing,
    packaging, labeling, distribution, importation, sale and storage
    of our products; (2) product claims and advertising,
    including direct claims and advertising by us, as well as claims
    and advertising by distributors, for which we may be held
    responsible; (3) our network marketing program;
    (4) transfer pricing and similar regulations that affect
    the level of U.S. and foreign taxable income and customs
    duties; and (5) taxation of our independent distributors
    (which in some instances may impose an obligation on us to
    collect the taxes and maintain appropriate records).
 
    Products
 
    In the United States, the formulation, manufacturing, packaging,
    storing, labeling, promotion, advertising, distribution and sale
    of our products are subject to regulation by various
    governmental agencies, including (1) the Food and Drug
    Administration, or FDA, (2) the Federal Trade Commission,
    or FTC, (3) the Consumer Product Safety Commission, or
    CPSC, (4) the United States Department of Agriculture, or
    USDA, (5) the Environmental Protection Agency, or EPA,
    (6) the United States Postal Service, (7) United
    States Customs and Border Protection, and (8) the Drug
    Enforcement Administration. Our activities also are regulated by
    various agencies of the states, localities and foreign countries
    in which our products are manufactured, distributed and sold.
    The FDA, in particular, regulates the formulation, manufacture
    and labeling of over-the-counter, or OTC, drugs, conventional
    foods, dietary supplements, and cosmetics such as those
    distributed by us. FDA regulations require us and our suppliers
    to meet relevant current good manufacturing practice, or cGMP,
    regulations for the preparation, packing and storage of foods
    and OTC drugs. On June 25, 2007, the FDA published its
    final rule regulating cGMPs for dietary supplements. The final
    rule became effective August 24, 2007 and large companies
    such as Herbalife will have June 2008 to achieve compliance. We
    expect to see an increase in certain manufacturing costs as a
    result of the necessary increase in testing of raw ingredients
    and finished products and compliance with higher quality
    standards.
 
    Most OTC drugs are subject to FDA Monographs that establish
    labeling and composition for these products. Those of our
    products which are classified as OTC must comply with these
    Monographs, and our manufacturers must list all products with
    the FDA and follow cGMP. Our cosmetic products are regulated for
    safety by the FDA, which requires that ingredients meet industry
    standards for non-allergenicity and non-toxicity. Performance
    claims for cosmetics may not be therapeutic.
 
    The U.S. 1994 Dietary Supplement Health and Education Act,
    or DSHEA, revised the provisions of the Federal Food, Drug and
    Cosmetic Act, or FFDCA, concerning the composition and labeling
    of dietary supplements and, we believe, is generally favorable
    to the dietary supplement industry. The legislation created a
    new statutory class of dietary supplements. This new class
    includes vitamins, minerals, herbs, amino acids and other
    dietary substances for human use to supplement the diet, and the
    legislation grandfathers, with some limitations, dietary
    ingredients that were on the market before October 15,
    1994. A dietary supplement that contains a dietary ingredient
    that was not on the market before October 15, 1994 will
    require evidence of a history of use or other evidence of safety
    establishing that it is reasonably expected to be safe.
    Manufacturers or marketers of dietary supplements in
    
    15
 
 
    the United States and certain other jurisdictions that make
    product performance claims, including structure or function
    claims, must have substantiation in their possession that the
    statements are truthful and not misleading. The majority of the
    products marketed by us in the United States are classified as
    conventional foods or dietary supplements under the FFDCA.
    Internationally, the majority of products marketed by us are
    classified as foods or food supplements.
 
    In January 2000, the FDA issued a regulation that defines the
    types of statements that can be made concerning the effect of a
    dietary supplement on the structure or function of the body
    pursuant to DSHEA. Under DSHEA, dietary supplement labeling may
    bear structure or function claims, which are claims that the
    products affect the structure or function of the body, without
    prior FDA approval, but with notification to the FDA. They may
    not bear a claim that they can prevent, treat, cure, mitigate or
    diagnose disease (a disease claim). The regulation describes how
    the FDA distinguishes disease claims from structure or function
    claims. During 2004, the FDA issued a guidance, paralleling an
    earlier guidance from the FTC, defining a manufacturers
    obligations to substantiate structure/function claims. The FDA
    also issued a Structure/Function Claims Small Entity Compliance
    Guide. In addition, the agency permits companies to use
    FDA-approved full and qualified health claims for products
    containing specific ingredients that meet stated requirements.
 
    As a marketer of dietary and nutritional supplements and other
    products that are ingested by consumers, we are subject to the
    risk that one or more of the ingredients in our products may
    become the subject of regulatory action. A number of states
    restricted the sale of dietary supplements containing botanical
    sources of ephedrine alkaloids. As a result of these state
    regulations, we stopped sales of dietary supplements containing
    botanical sources of ephedrine alkaloids due to a shift in
    consumer preference for ephedra free products and a
    significant increase in products liability insurance premiums
    for products containing botanical sources of ephedrine group
    alkaloids. On December 31, 2002, we ceased sales of
    Thermojetics®
    original green herbal tablets containing ephedrine alkaloids
    derived from Chinese Ma huang, as well as
    Thermojetics®
    green herbal tablets and
    Thermojetics®
    gold herbal tablets (the latter two containing the herb Sida
    cordifolia which is another botanical source of ephedrine
    alkaloids). On February 6, 2004, the FDA published a rule
    finding that dietary supplements containing ephedrine alkaloids
    present an unreasonable risk of illness or injury under
    conditions of use recommended or suggested in the labeling of
    the product, or, if no conditions of use are suggested in the
    labeling, under ordinary conditions of use, and are therefore
    adulterated.
 
    The FDA has on record a small number of reports of adverse
    reactions allegedly resulting from the ingestion of our
    Thermojetics®
    original green tablet. These reports are among thousands of
    reports of adverse reactions to these products sold by other
    companies.
 
    As a further outgrowth of the FDA ephedra safety review, the
    FDA, in January 2004, announced that it would undertake a review
    of the safety of the herb Citrus aurantium. We had
    previously used Citrus aurantium in the
    ShapeWorks®
    Total
    Control®
    and
    Thermojetics®
    green ephedra-free dietary supplements sold in the United States
    and in a number of international markets. Unconfirmed reports of
    serious adverse events, reportedly associated with Citrus
    aurantium, were disclosed by the FDA to the New York Times
    during April 2004. Under the Freedom of Information Act, we
    obtained a copy of those anecdotal serious adverse event
    reports. No Herbalife dietary supplement containing Citrus
    aurantium was cited by the FDA. Indeed, many cited products
    from other companies did not even contain Citrus aurantium.
    Nonetheless, we decided to reformulate our products and we
    no longer market dietary supplements containing Citrus
    aurantium anywhere in the world.
 
    The FDAs decision to ban ephedra triggered a significant
    reaction by the national media, some of whom are calling for the
    repeal or amendment of DSHEA. These media view supposed
    weaknesses within DSHEA as the underlying reason why
    ephedra was allowed to remain on the market. We have been
    advised that DSHEA opponents in Congress may use this anti-DSHEA
    momentum to advance new legislation during the
    110th Congress to amend or repeal DSHEA. If this should
    occur we believe that the DSHEA opponents may propose the
    following: (1) premarket approval for safety and
    effectiveness of dietary ingredients; (2) specific
    premarket review of dietary ingredient stimulants that are being
    used to replace ephedra; (3) reversal of the burden of
    proof standard which now rests on the FDA; and (4) a
    redefining of dietary ingredient to remove either
    botanicals or selected classes of ingredients now treated as
    dietary ingredients.
 
    On December 22, 2007, a new law went into effect in the
    United States mandating the reporting of all serious adverse
    events occurring within the United States which involve dietary
    supplements or OTC drugs. We believe that
    
    16
 
 
    we are in full compliance with this new law having promulgated
    and implemented a worldwide procedure governing adverse event
    identification, investigation and reporting which is managed by
    our Scientific Affairs department in collaboration with our
    Medical Affairs department and our Distributor Relations Call
    Centers. As a result of our receipt of adverse event reports, we
    may from time to time elect, or be required, to remove a product
    from a market, either temporarily or permanently.
 
    On June 25, 2007, the FDA published its final rule
    regulating current good manufacturing practices, or cGMP, for
    dietary supplements. This final rule became effective on
    August 24, 2007, and Herbalife will have until June, 2008
    to achieve compliance. The final rule requires that companies
    establish written procedures governing: (1) personnel,
    (2) plant and equipment cleanliness, (3) lab and
    testing, (4) packaging and labeling, and
    (5) distribution. The FDA also required 100 percent
    identity testing of all incoming raw materials, although an
    interim final rule enables companies to petition for an
    exemption from the 100 percent testing requirement if they
    can demonstrate the existence of an appropriate statistical
    sampling program. The new cGMPs will help ensure that dietary
    supplements and dietary ingredients are not adulterated with
    contaminants or impurities, and are labeled to accurately
    reflect the active ingredients and other ingredients in the
    products. We have evaluated the final cGMP rule with respect to
    its potential impact upon the various contract manufacturers
    that we use to manufacture our products, some of which might not
    meet the new standards. It is important to note that the final
    cGMP rule, in an effort to limit disruption, includes a
    three-year phase-in for small businesses. This will mean that
    some of our contract manufacturers will not be fully impacted by
    the proposed regulation until at least 2010. However, the final
    cGMP rule can be expected to result in additional costs and
    possibly the need to seek alternate suppliers. See
    Item 1A  Risk Factors for further discussion
    regarding the recently promulgated cGMP regulations.
 
    Some of the products marketed by us are considered conventional
    foods and are currently labeled as such. Within the United
    States, this category of products is subject to the Nutrition,
    Labeling and Education Act, or NLEA, and regulations promulgated
    under the NLEA. The NLEA regulates health claims, ingredient
    labeling and nutrient content claims characterizing the level of
    a nutrient in the product. The ingredients added to conventional
    foods must either be generally recognized as safe by experts, or
    GRAS, or be approved as food additives under FDA regulations.
 
    In foreign markets, prior to commencing operations and prior to
    making or permitting sales of our products in the market, we may
    be required to obtain an approval, license or certification from
    the relevant countrys ministry of health or comparable
    agency. Where a formal approval, license or certification is not
    required, we nonetheless seek a favorable opinion of counsel
    regarding our compliance with applicable laws. Prior to entering
    a new market in which a formal approval, license or certificate
    is required, we work extensively with local authorities in order
    to obtain the requisite approvals. The approval process
    generally requires us to present each product and product
    ingredient to appropriate regulators and, in some instances,
    arrange for testing of products by local technicians for
    ingredient analysis. The approvals may be conditioned on
    reformulation of our products, or may be unavailable with
    respect to some products or some ingredients. Product
    reformulation or the inability to introduce some products or
    ingredients into a particular market may have an adverse effect
    on sales. We must also comply with product labeling and
    packaging regulations that vary from country to country. Our
    failure to comply with these regulations can result in a product
    being removed from sale in a particular market, either
    temporarily or permanently.
 
    In 2005, Herbalife voluntarily elected to temporarily withdraw
    its Sesame & Herb tablet product from the Israeli
    market. This product, which has been on the market since 1989,
    was sold only in Israel. Herbalifes voluntary decision to
    temporarily withdraw this product accompanied the initiation of
    a review by the Israeli Ministry of Health of anecdotal case
    reports of individuals having varying liver conditions when it
    was reported that a small number of these individuals had
    consumed Herbalife products. Herbalife scientists and medical
    doctors have closely cooperated with the Ministry of Health to
    facilitate this review. This review is ongoing and there can be
    no assurances as to the outcome.
 
    The FTC, which exercises jurisdiction over the advertising of
    all of our products, has in the past several years instituted
    enforcement actions against several dietary supplement companies
    and against manufacturers of weight loss products generally for
    false and misleading advertising of some of their products.
    These enforcement actions have often resulted in consent decrees
    and monetary payments by the companies involved. In addition,
    the FTC has increased its scrutiny of the use of testimonials,
    which we also utilize, as well as the role of expert endorsers
    and
    
    17
 
 
    product clinical studies. Although we have not been the target
    of FTC enforcement action for the advertising of our products,
    we cannot be sure that the FTC, or comparable foreign agencies,
    will not question our advertising or other operations in the
    future. It is unclear whether the FTC will subject our
    advertisements to increased surveillance to ensure compliance
    with the principles set forth in its published advertising
    guidance.
 
    In Europe, an EU Health Claim regulation was recently finalized.
    The final regulation will have an adverse effect on existing
    product wellness, well-being and
    good for you claims presently made on existing
    product labeling, literature and advertising. Herbalife is
    currently assembling the necessary scientific substantiation for
    its European product claims based on the requirements of this
    recently enacted regulation.
 
    In some countries, regulations applicable to the activities of
    our distributors also may affect our business because in some
    countries we are, or regulators may assert that we are,
    responsible for our distributors conduct. In these
    countries, regulators may request or require that we take steps
    to ensure that our distributors comply with local regulations.
    The types of regulated conduct include: (1) representations
    concerning our products; (2) income representations made by
    us and/or
    distributors; (3) public media advertisements, which in
    foreign markets may require prior approval by regulators; and
    (4) sales of products in markets in which the products have
    not been approved, licensed or certified for sale.
 
    In some markets, it is possible that improper product claims by
    distributors could result in our products being reviewed by
    regulatory authorities and, as a result, being classified or
    placed into another category as to which stricter regulations
    are applicable. In addition, we might be required to make
    labeling changes.
 
    We are unable to predict the nature of any future laws,
    regulations, interpretations or applications, nor can we predict
    what effect additional governmental regulations or
    administrative orders, when and if promulgated, would have on
    our business in the future. They could, however, require:
    (1) the reformulation of some products not capable of being
    reformulated; (2) imposition of additional record keeping
    requirements; (3) expanded documentation of the properties
    of some products; (4) expanded or different labeling;
    (5) additional scientific substantiation regarding product
    ingredients, safety or usefulness;
    and/or
    (6) additional distributor compliance surveillance and
    enforcement action by us.
 
    Any or all of these requirements could have a material adverse
    effect on our results of operations and financial condition. All
    of our officers and directors are subject to a permanent
    injunction issued in October 1986 pursuant to the settlement of
    an action instituted by the California Attorney General, the
    State Health Director and the Santa Cruz County District
    Attorney. We consented to the entry of this injunction without
    in any way admitting the allegations of the complaint. The
    injunction prevents us and our officers and directors from
    making specified claims in future advertising of our products
    and required us to implement some documentation systems with
    respect to payments to our distributors. At the same time, the
    injunction does not prevent us from continuing to make specified
    claims concerning our products that have been made and are being
    made, provided that we have a reasonable basis for making the
    claims.
 
    We are aware that, in some of our international markets, there
    has been recent adverse publicity concerning products that
    contain ingredients that have been genetically modified, or GM.
    In some markets, the possibility of health risks or perceived
    consumer preference thought to be associated with GM ingredients
    has prompted proposed or actual governmental regulation. For
    example, the European Union has adopted a EC
    Regulation 1829/2003 affecting the labeling of products
    containing ingredients that have been genetically modified, and
    the documents manufacturers and marketers will need to possess
    to ensure traceability at all steps in the chain of
    production and distribution. This new regulation, which took
    effect in 2004, has been implemented by us and our contract
    manufacturers, resulting in modifications to our labeling, and
    in some instances, to some of our foods and food supplements
    sold in Europe. Differing GM regulations affecting us also have
    been adopted in Brazil, Japan, Korea, Taiwan and Thailand. We
    cannot anticipate the extent to which future regulations in our
    markets will restrict the use of GM ingredients in our products
    or the impact of any regulations on our business in those
    markets. In response to any applicable regulations, we would,
    where practicable, attempt to reformulate our products to
    satisfy the regulations. We believe, based upon currently
    available information, that compliance with regulatory
    requirements in this area should not have a material adverse
    effect on us or our business. However, because publicity and
    governmental scrutiny of GM ingredients is a relatively new and
    evolving area, there can be no assurance in this regard. If a
    significant number of our products were found to be genetically
    modified and regulations in our markets
    
    18
 
 
    significantly restricted the use of GM ingredients in our
    products, our business could be materially adversely affected.
 
    We have been required to comply with recent regulations within
    the European Union, Australia, Brazil, Canada, China, Hong Kong,
    Japan, Taiwan, and Thailand affecting the use
    and/or
    labeling of irradiated raw ingredients.
 
    Compliance with GM, BSE and irradiation regulations can be
    expected to increase the cost of manufacturing certain of our
    products.
 
    Network
    Marketing Program
 
    Our network marketing program is subject to a number of federal
    and state regulations administered by the FTC and various state
    agencies as well as regulations in foreign markets administered
    by foreign agencies. Regulations applicable to network marketing
    organizations generally are directed at ensuring that product
    sales ultimately are made to consumers and that advancement
    within our organization is based on sales of the
    organizations products rather than investments in the
    organization or other non-retail sales related criteria. For
    instance, in some markets, there are limits on the extent to
    which distributors may earn royalty overrides on sales generated
    by distributors that were not directly sponsored by the
    distributor. When required by law, we obtain regulatory approval
    of our network marketing program or, when this approval is not
    required, the favorable opinion of local counsel as to
    regulatory compliance. Nevertheless, we remain subject to the
    risk that, in one or more markets, our marketing system could be
    found not to be in compliance with applicable regulations.
    Failure by us to comply with these regulations could have a
    material adverse effect on our business in a particular market
    or in general.
 
    On April 12, 2006, the FTC, issued a notice of proposed
    rulemaking which, if implemented, will regulate all sellers of
    business opportunities in the United States. The
    proposed rule would, among other things, require all sellers of
    business opportunities, which would likely include Herbalife, to
    (i) implement a seven day waiting period before entering
    into an agreement with a prospective business opportunity
    purchaser, and (ii) provide all prospective business
    opportunity purchasers with substantial information in writing
    at the beginning of the waiting period regarding the business
    opportunity, including information relating to: representations
    made as to the earnings experience of other business opportunity
    purchasers, the names and telephone numbers of recent purchasers
    in their geographic area, cancellation or refund policies and
    requests within the prior two years, certain legal actions
    against the company, its affiliated companies and company
    officers, directors, sales managers and certain others. We,
    other direct selling companies, the Direct Selling Association,
    or the DSA, and other interested parties have filed over 17,000
    comments with the FTC that are publicly available regarding the
    proposed rule through the FTCs website at
    http://www.ftc.gov/os/comments/businessopprule/index.htm.
    We, the DSA, other direct selling companies, and other
    interested parties also filed rebuttal comments with
    the FTC in September, 2006. Based on information currently
    available, we anticipate that the final rule may require several
    years to become final and effective, and may differ
    substantially from the rule as originally proposed. Nevertheless
    the proposed rule, if implemented in its original form, would
    negatively impact our U.S. business.
 
    We also are subject to the risk of private party challenges to
    the legality of our network marketing program. For example, in
    Webster v. Omnitrition International, Inc., 79 F.3d
    776 (9th Cir. 1996), the multi-level marketing program of
    Omnitrition International, Inc., or Omnitrition, was
    successfully challenged in a class action by Omnitrition
    distributors who alleged that Omnitrition was operating an
    illegal pyramid scheme in violation of federal and
    state laws. We believe that our network marketing program
    satisfies the standards set forth in the Omnitrition case and
    other applicable statutes and case law defining a legal
    marketing system, in part based upon significant differences
    between our marketing system and that described in the
    Omnitrition case.
 
    Herbalife International and certain of its independent
    distributors have been named as defendants in a purported class
    action lawsuit filed February 17, 2005, in the Superior
    Court of California, County of San Francisco, and served on
    Herbalife International on March 14, 2005
    (Minton v. Herbalife International, et al). The case
    has been transferred to the Los Angeles County Superior Court.
    The plaintiff is challenging the marketing practices of certain
    Herbalife International independent distributors and Herbalife
    International under various state laws prohibiting endless
    chain schemes, insufficient disclosure in assisted
    marketing plans, unfair and deceptive
    
    19
 
 
    business practices, and fraud and deceit. The plaintiff alleges
    that the Freedom Group system operated by certain independent
    distributors of Herbalife International products places too much
    emphasis on recruiting and encourages excessively large
    purchases of product and promotional materials by distributors.
    The plaintiff also alleges that Freedom Group pressured
    distributors to disseminate misleading promotional materials.
    The plaintiff seeks to hold Herbalife International vicariously
    liable for the actions of its independent distributors and is
    seeking damages and injunctive relief. On January 24, 2007,
    the Superior Court denied class certification of all claims,
    except for the claim under California law prohibiting
    endless chain schemes. That claim was granted
    California-only class certification, provided that class counsel
    is able to substitute in as a plaintiff a California resident
    with claims typical of the class. We believe that we have
    meritorious defenses to the suit.
 
    Herbalife International and certain of its distributors were
    defendants in a class action lawsuit filed July 16, 2003,
    in the Circuit Court of Ohio County in the State of West
    Virginia (Mey v. Herbalife International, Inc., et
    al). The complaint alleged that certain telemarketing
    practices of certain Herbalife International distributors
    violated the Telephone Consumer Protection Act, or TCPA, and
    sought to hold Herbalife International vicariously liable for
    the practices of its independent distributors. More
    specifically, the plaintiffs complaint alleged that
    several of Herbalife Internationals distributors used
    pre-recorded telephone messages and faxes to contact prospective
    customers in violation of the TCPAs prohibition of such
    practices. Without in any way acknowledging liability or
    wrongdoing by us or our independent distributors, we and the
    other defendants have reached a binding settlement with the
    plaintiffs. Under the terms of the settlement the defendants
    collectively paid $7 million into a fund to be distributed
    to qualifying class members. The relevant amount paid by us was
    previously fully reserved in our financial statements. The
    settlement has received the final approval of the Court in
    January 2008.
 
    We are also subject to the risk of private party challenges to
    the legality of our network marketing program. The multi-level
    marketing programs of other companies have been successfully
    challenged in the past, and in a current lawsuit, allegations
    have been made challenging the legality of our network marketing
    program in Belgium. Test Ankoop-Test Achat, a Belgian consumer
    protection organization, sued Herbalife International Belgium,
    S.V., or HIB, on August 26, 2004, alleging that HIB
    violated Article 84 of the Belgian Fair Trade Practices Act
    by engaging in pyramid selling, i.e., establishing a
    network of professional or non-professional sales people who
    hope to make a profit more through the expansion of that network
    rather than through the sale of products to end-consumers. The
    plaintiff is seeking a payment of 25,000 (equal to
    approximately $36,500 as of December 31, 2007) per
    purported violation as well as costs of the trial. For the year
    ended December 31, 2007, our net sales in Belgium were
    approximately $16.0 million. Currently, the lawsuit is in
    the pleading stage. The plaintiffs filed their initial brief on
    September 27, 2005. We filed a reply brief on May 9,
    2006. There is no date yet for the oral hearings. An adverse
    judicial determination with respect to our network marketing
    program, or in proceedings not involving us directly but which
    challenge the legality of multi-level marketing systems, in
    Belgium or in any other market in which we operate, could
    negatively impact our business.
 
    It is an ongoing part of our business to monitor and respond to
    regulatory and legal developments, including those that may
    affect our network marketing program. However, the regulatory
    requirements concerning network marketing programs do not
    include bright line rules and are inherently fact-based. An
    adverse judicial determination with respect to our network
    marketing program could have a material adverse effect on our
    business. An adverse determination could: (1) require us to
    make modifications to our network marketing program,
    (2) result in negative publicity or (3) have a
    negative impact on distributor morale. In addition, adverse
    rulings by courts in any proceedings challenging the legality of
    multi-level marketing systems, even in those not involving us
    directly, could have a material adverse effect on our operations.
 
    Transfer
    Pricing and Similar Regulations
 
    In many countries, including the United States, we are subject
    to transfer pricing and other tax regulations designed to ensure
    that appropriate levels of income are reported as earned by our
    U.S. or local entities and are taxed accordingly. In
    addition, our operations are subject to regulations designed to
    ensure that appropriate levels of customs duties are assessed on
    the importation of our products.
 
    Although we believe that we are in substantial compliance with
    all applicable regulations and restrictions, we are subject to
    the risk that governmental authorities could audit our transfer
    pricing and related practices and assert
    
    20
 
 
    that additional taxes are owed. For example, we are currently
    subject to pending or proposed audits that are at various levels
    of review, assessment or appeal in a number of jurisdictions
    involving transfer pricing issues, income taxes, duties, value
    added taxes, withholding taxes and related interest and
    penalties in material amounts. In some circumstances, additional
    taxes, interest and penalties have been assessed, and we will be
    required to appeal or litigate to reverse the assessments. We
    have taken advice from our tax advisors and believe that there
    are substantial defenses to the allegations that additional
    taxes are owed, and we are vigorously defending against the
    imposition of additional proposed taxes. The ultimate resolution
    of these matters may take several years, and the outcome is
    uncertain.
 
    In the event that the audits or assessments are concluded
    adversely to us, we may or may not be able to offset or mitigate
    the consolidated effect of foreign income tax assessments
    through the use of U.S. foreign tax credits. Currently, we
    anticipate utilizing the majority of our foreign tax credits in
    the year in which they arise with the unused amount carried
    forward. Because the laws and regulations governing
    U.S. foreign tax credits are complex and subject to
    periodic legislative amendment, we cannot be sure that we would
    in fact be able to take advantage of any foreign tax credits in
    the future. As a result, adverse outcomes in these matters could
    have a material impact on our financial condition and operating
    results.
 
    Other
    Regulations
 
    We also are subject to a variety of other regulations in various
    foreign markets, including regulations pertaining to social
    security assessments, employment and severance pay requirements,
    import/export regulations and antitrust issues. As an example,
    in many markets, we are substantially restricted in the amount
    and types of rules and termination criteria that we can impose
    on distributors without having to pay social security
    assessments on behalf of the distributors and without incurring
    severance obligations to terminated distributors. In some
    countries, we may be subject to these obligations in any event.
 
    Our failure to comply with these regulations could have a
    material adverse effect on our business in a particular market
    or in general. Assertions that we failed to comply with
    regulations or the effect of adverse regulations in one market
    could adversely affect us in other markets as well by causing
    increased regulatory scrutiny in those other markets or as a
    result of the negative publicity generated in those other
    markets.
 
    Compliance
    Procedures
 
    As indicated above, Herbalife, our products and our network
    marketing program are subject, both directly and indirectly
    through distributors conduct, to numerous federal, state
    and local regulations, both in the United States and foreign
    markets. Beginning in 1985, we began to institute formal
    regulatory compliance measures by developing a system to
    identify specific complaints against distributors and to remedy
    any violations of Herbalifes rules by distributors through
    appropriate sanctions, including warnings, suspensions and, when
    necessary, terminations. In our manuals, seminars and other
    training programs and materials, we emphasize that distributors
    are prohibited from making therapeutic claims for our products.
 
    Our general policy regarding acceptance of distributor
    applications from individuals who do not reside in one of our
    markets is to refuse to accept the individuals distributor
    application. From time to time, exceptions to the policy are
    made on a
    country-by-country
    basis.
 
    In order to comply with regulations that apply to both us and
    our distributors, we conduct considerable research into the
    applicable regulatory framework prior to entering any new market
    to identify all necessary licenses and approvals and applicable
    limitations on our operations in that market. Typically, we
    conduct this research with the assistance of local legal counsel
    and other representatives. We devote substantial resources to
    obtaining the necessary licenses and approvals and bringing our
    operations into compliance with the applicable limitations. We
    also research laws applicable to distributor operations and
    revise or alter our distributor manuals and other training
    materials and programs to provide distributors with guidelines
    for operating a business, marketing and distributing our
    products and similar matters, as required by applicable
    regulations in each market. We, however, are unable to monitor
    our supervisors and distributors effectively to ensure that they
    refrain from distributing our products in countries where we
    have not commenced operations, and we do not devote significant
    resources to this type of monitoring.
    
    21
 
 
    In addition, regulations in existing and new markets often are
    ambiguous and subject to considerable interpretive and
    enforcement discretion by the responsible regulators. Moreover,
    even when we believe that we and our distributors are initially
    in compliance with all applicable regulations, new regulations
    regularly are being added and the interpretation of existing
    regulations is subject to change. Further, the content and
    impact of regulations to which we are subject may be influenced
    by public attention directed at us, our products or our network
    marketing program, so that extensive adverse publicity about us,
    our products or our network marketing program may result in
    increased regulatory scrutiny.
 
    It is an ongoing part of our business to anticipate and respond
    to new and changing regulations and to make corresponding
    changes in our operations to the extent practicable. Although we
    devote considerable resources to maintaining our compliance with
    regulatory constraints in each of our markets, we cannot be sure
    that (1) we would be found to be in full compliance with
    applicable regulations in all of our markets at any given time
    or (2) the regulatory authorities in one or more markets
    will not assert, either retroactively or prospectively or both,
    that our operations are not in full compliance. These assertions
    or the effect of adverse regulations in one market could
    negatively affect us in other markets as well by causing
    increased regulatory scrutiny in those other markets or as a
    result of the negative publicity generated in those other
    markets. These assertions could have a material adverse effect
    on us in a particular market or in general. Furthermore,
    depending upon the severity of regulatory changes in a
    particular market and the changes in our operations that would
    be necessitated to maintain compliance, these changes could
    result in our experiencing a material reduction in sales in the
    market or determining to exit the market altogether. In this
    event, we would attempt to devote the resources previously
    devoted to the market, to a new market or markets or other
    existing markets. However, we cannot be sure that this
    transition would not have an adverse effect on our business and
    results of operations either in the short or long-term.
 
    Trademarks
    and Proprietary Formulas
 
    We use the umbrella trademarks Herbalife and the Tri-Leaf design
    worldwide, and protect several other trademarks and trade names
    related to our products and operations, such as
    Shapeworks®,
    Nourifusion®,
    and
    Liftoff®.
    Our trademark registrations are issued through the United States
    Patent and Trademark Office and comparable agencies in the
    foreign countries. We consider our trademarks and trade names to
    be an important factor in our business. We also take care in
    protecting the intellectual property rights of our proprietary
    formulas by restricting access to our formulas within the
    Company to those persons or departments that require access to
    them to perform their functions, and by requiring our finished
    goods-suppliers and consultants to execute supply and
    non-disclosure agreements that seek to contractually protect our
    intellectual property rights. Disclosure of these formulas, in
    redacted form, is also necessary to obtain sanitary
    registrations in many countries. We also make efforts to protect
    some unique formulations under patent law. For example, we have
    sought through our employee inventors one or more patents in the
    United States and certain other markets to protect the
    formulation of the
    Liftoff®
    brand effervescent supplement. The United States Patent
    Office has recently granted patent no. 7,329,419 to our
    employee inventors for the composition that constitutes the
    current U.S. Total
    Control®
    product formula. All rights in this patent have been
    assigned to Herbalife. We strive to protect all new product
    developments as the confidential trade secrets of the Company
    and its inventor employees. However, despite our efforts, we may
    be unable to prevent third parties from infringing upon or
    misappropriating our proprietary rights.
 
    Competition
 
    The business of marketing weight management and nutrition
    products is highly competitive. This market segment includes
    numerous manufacturers, distributors, marketers, retailers and
    physicians that actively compete for the business of consumers
    both in the United States and abroad. The market is highly
    sensitive to the introduction of new products or weight
    management plans, including various prescription and over the
    counter drugs that may rapidly capture a significant share of
    the market. As a result, our ability to remain competitive
    depends in part upon the successful introduction of new
    products. In addition, we anticipate that we will be subject to
    increasing competition in the future from sellers that utilize
    electronic commerce. We cannot be sure of the impact of
    electronic commerce or that it will not adversely affect our
    business.
 
    We are subject to significant competition for the recruitment of
    distributors from other network marketing organizations,
    including those that market weight management products,
    nutritional supplements and personal care
    
    22
 
 
    products, as well as other types of products. Some of our
    competitors are substantially larger than we are, and have
    considerably greater financial resources than we have. Our
    ability to remain competitive depends, in significant part, on
    our success in recruiting and retaining distributors through an
    attractive compensation plan and other incentives. We believe
    that our production bonus program, international sponsorship
    program and other compensation and incentive programs provide
    our distributors with significant earning potential. However, we
    cannot be sure that our programs for recruitment and retention
    of distributors will be successful.
 
    Executive
    Officers of the Registrant
 
    The table sets forth certain information, as of
    December 31, 2007, regarding each person who serves as an
    executive officer of the Company.
 
    |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  | Officer 
 | 
| 
    Name
 |  | 
    Age
 |  | 
    Position with the Company
 |  | 
    Since
 | 
|  | 
| 
    Michael O. Johnson
 |  |  | 53 |  |  | Chief Executive Officer, Director, Chairman of the Board |  |  | 2003 |  | 
| 
    Gregory Probert
 |  |  | 51 |  |  | President, Chief Operating Officer |  |  | 2003 |  | 
| 
    Richard Goudis
 |  |  | 46 |  |  | Chief Financial Officer |  |  | 2004 |  | 
| 
    Brett R. Chapman
 |  |  | 52 |  |  | General Counsel and Corporate Secretary |  |  | 2003 |  | 
| 
    Steve Henig Ph.D. 
 |  |  | 65 |  |  | Chief Scientific Officer |  |  | 2005 |  | 
 
    Michael O. Johnson is Chairman and Chief Executive
    Officer of the Company. Mr. Johnson joined the Company in
    April 2003 after 17 years with The Walt Disney Company,
    where he most recently served as President of Walt Disney
    International, and also served as President of Asia Pacific for
    The Walt Disney Company and President of Buena Vista Home
    Entertainment. Mr. Johnson has also previously served as a
    publisher of Audio Times magazine, and has directed the
    regional sales efforts of Warner Amex Satellite Entertainment
    Company for three of its television channels, including MTV,
    Nickelodeon and The Movie Channel. Mr. Johnson formerly
    served as a director of Univision Communications, Inc., a
    television company serving Spanish-speaking Americans and
    currently serves on the board of Loyola High School of Los
    Angeles. Mr. Johnson received his Bachelor of Arts in
    Political Science from Western State College.
 
    Gregory Probert is President and Chief Operating Officer
    of the Company. Mr. Probert joined the Company in August
    2003, after serving as President and CEO of DMX MUSIC for over
    2 years. Mr. Probert joined DMX MUSIC after serving as
    Chief Operating Officer of planet Lingo, where he led the team
    that designed and built the companys first product, an
    online conversational system for the $20 billion ESL market
    in Japan. Immediately prior to planet Lingo, Mr. Probert
    spent 12 years with The Walt Disney Company, where he most
    recently served as Executive Vice President for the
    $3.5 billion Buena Vista Home Entertainment worldwide
    business. Mr. Proberts positions with The Walt Disney
    Company also included service as Executive Vice President of the
    International Home Video Division, Senior Vice President and
    Managing Director of Buena Vista Home Entertainment, Asia
    Pacific Region, based in Hong Kong, and Vice President Financial
    of Buena Vista International, Disneys theatrical
    distribution arm, among others. Mr. Probert received his
    Bachelor of Arts from the University of Southern California.
 
    Richard Goudis is Chief Financial Officer of the Company.
    Mr. Goudis joined the Company in June 2004 after serving as
    the Chief Operating Officer of Rexall Sundown, a Nasdaq
    100 company that was sold to Royal Numico in 2000, from
    1998 to 2001. After the sale to Royal Numico, Mr. Goudis
    had operations responsibility for all of Royal Numicos
    U.S. investments, including General Nutrition Centers, or
    GNC, Unicity International and Rexall Sundown. From 2002 to
    May 2004, Mr. Goudis was a partner at Flamingo Capital
    Partners, a firm he founded with several retired executives from
    Rexall Sundown. Prior to working at Rexall Sundown,
    Mr. Goudis worked at Sunbeam Corporation and
    Pratt & Whitney. Mr. Goudis graduated from the
    University of Massachusetts with a degree in Accounting and he
    received his MBA from Nova Southeastern University.
 
    Brett R. Chapman is General Counsel and Secretary of the
    Company. Mr. Chapman joined the Company in October 2003
    after spending thirteen years at The Walt Disney Company, most
    recently as its Senior Vice President and Deputy General
    Counsel, with responsibility for all legal matters relating to
    Disneys Media Networks Group,
    
    23
 
 
    including the ABC Television Network, the companys cable
    properties including The Disney Channel and ESPN, and
    Disneys radio and internet businesses. Prior to working at
    The Walt Disney Company, Mr. Chapman was an associate at
    the law firm of Skadden, Arps, Slate, Meagher & Flom
    LLP. Mr. Chapman received his Bachelor of Science and
    Master of Science in Business Administration from California
    State University, Northridge and his Juris Doctorate from
    Southwestern University School of Law.
 
    Steve Henig, Ph.D. is Chief Scientific Officer of
    the Company. Mr. Henig joined the Company in July 2005
    after spending 6 years at Ocean Spray Cranberries, Inc., as
    Senior Vice President, technology and innovation with
    responsibility for the companys new products program and
    medical research program. Prior to working at Ocean Spray
    Cranberries, Inc. Mr. Henig served as Senior Vice
    President, technology and marketing services at Con Agras
    Grocery products. Mr. Henig holds a Ph.D. in food science
    from Rutgers University, a M.S. in food and biotechnology and a
    B.S. in chemical engineering from Technion-Israel Institute of
    Technology.
 
    Employees
 
    As of December 31, 2007, we had approximately
    3,600 employees. In China, as of December 31, 2007, we
    also had labor contracts with approximately 22,000 employed
    sales representatives. These numbers do not include our
    distributors, who are independent contractors rather than
    employees. Except for some employees in Mexico and in certain
    European countries, none of our employees are members of any
    labor union, and we have never experienced any business
    interruption as a result of any labor disputes.
 
    Available
    Information
 
    Our internet website address is www.Herbalife.com. We
    make available free of charge on our website our Annual Reports
    on
    Form 10-K,
    Quarterly Reports on
    Form 10-Q,
    Current Reports on
    Form 8-K
    and amendments to those reports filed or furnished pursuant to
    Section 13(a) or 15(d) of the Securities Exchange Act of
    1934, as amended, or the Exchange Act, as soon as reasonably
    practical after we file such material with, or furnish it to,
    the Securities and Exchange Commission, or SEC. This information
    is also available in print to any shareholder who request it,
    with any such requests addressed to Investor Relations, 1800
    Century Park East, Los Angeles, CA 90067. Certain of these
    documents may also be obtained by calling the SEC at
    1-800-SEC-0330.
    The SEC also maintains an Internet website that contains
    reports, and other information regarding issuers that file
    electronically with the SEC at www.sec.gov. We also make
    available free of charge on our website our Corporate Governance
    Guidelines, our Code of Business Conduct and Ethics, and the
    Charters of our Audit Committee, Corporate Governance and
    Nominating Committee, and Compensation Committee.
    
    24
 
 
 
    PART III.
 
    |  |  | 
    | Item 10. | DIRECTORS
    AND EXECUTIVE OFFICERS OF THE REGISTRANT | 
 
    The information required under this Item is incorporated herein
    by reference to our definitive proxy statement to be filed with
    the SEC no later than 120 days after the close of our
    fiscal year ended December 31, 2007, except that the
    information required with respect to our executive officers is
    set forth under Item 1  Business, of this
    Amendment, and is incorporated herein by reference.
 
    PART IV
 
    |  |  | 
    | Item 15. | EXHIBITS AND
    FINANCIAL STATEMENT SCHEDULES | 
 
    |  |  |  |  |  |  |  | 
| Exhibit 
 |  |  |  |  | 
| 
    Number
 |  | 
    Description
 |  | 
    Reference
 | 
|  | 
|  | 31 | .1 |  | Rule 13a-14(a)
    Certification of Chief Executive Officer |  | * | 
|  | 31 | .2 |  | Rule 13a-14(a)
    Certification of Chief Financial Officer |  | * | 
|  | 32 | .1 |  | Section 1350 Certification of Chief Executive Officer |  | * | 
|  | 32 | .2 |  | Section 1350 Certification of Chief Financial Officer |  | * | 
 
 
    
    25
 
 
 
    SIGNATURES
 
    Pursuant to the requirements of Section 13 or 15(d) of the
    Securities Exchange Act of 1934, the Registrant has duly caused
    this report to be signed on its behalf by the undersigned,
    thereto duly authorized.
 
    HERBALIFE Ltd.
 
    Richard Goudis
    Chief Financial Officer
 
    Dated: April 30, 2008
    
    26